Regulatory Roundup: Week of August 13: ISPE Issues Ozone Sanitization Guidance and EMA Amends Incident Management Plan - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Regulatory Roundup: Week of August 13: ISPE Issues Ozone Sanitization Guidance and EMA Amends Incident Management Plan


ISPE has issued ISPE Good Practice Guide: Ozone Sanitization of Pharmaceutical Water Systems, a new guidance document on the design and use of ozone systems for pharmaceutical water sanitization. The guide offers insight on ozone sanitization systems, including regulatory considerations, system operation, and qualification of ozone systems, to allow pharmaceutical companies to better understand ozone systems.

The European Union Regulatory Network Incident Management Plan for Medicines for Human Use has been amended by EMA to reflect 2010 pharmacovigilance legislation. The plan, in operation since September 2009, explains how safety and other drug incidents are monitored and addressed by the EMA, the European Commission, and regulatory agencies across the EU.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
26%
Oversee medical treatment of patients in the US.
12%
Provide treatment for patients globally.
10%
All of the above.
43%
No government involvement in patient treatment or drug development.
10%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?

Click here